Samsung Biologics
207940.KS
#399
Rank
A$77.35 B
Marketcap
$1,087
Share price
-0.50%
Change (1 day)
25.25%
Change (1 year)

Samsung Biologics (207940.KS) - Cash on Hand

Cash on Hand as of March 2024 : A$2.32 Billion

According to Samsung Biologics 's latest financial reports the company has A$2.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Samsung Biologics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$2.33 B-37.31%
2022-12-31A$3.72 B134.11%
2021-12-31A$1.58 B55.87%
2020-12-31A$1.01 B19.69%
2019-12-31A$0.85 B-40.62%
2018-12-31A$1.43 B213.75%
2017-12-31A$0.45 B-67.33%
2016-12-31A$1.40 B3374.22%
2015-12-31A$40.3 M-62.48%
2014-12-31A$0.10 B